Conexeu Sciences is trading at $3.13, -5.15%, amid broader risk-off sentiment.
- No new company-specific announcement explaining the October 23 move surfaced; the latest identified company news was an October 15 private placement.
- Markets faced pressure from Middle East tensions, higher oil prices and uncertainty around AI spending. Biotech shares were also weak, with healthcare stocks lower premarket and IBB down 1%.
- Trading volume information was unavailable in the reviewed sources.